Evidence map›Paper›PMID 29946445›Full record

ArticleF1000Research2018

The use of PrP transgenic

Alana M Thackray, Olivier Andréoletti, Raymond Bujdoso

Open access · goldAbstract read
In one paragraph

Article in F1000Research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 96% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Intrinsic determinants of prion protein neurotoxicity inFrontiers in molecular neuroscience · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Alana M ThackrayDepartment of Veterinary Medicine, University of Cambridge, Cambridge, CB3 OES, UK.ORCID https://orcid.org/0000-0002-2752-1127
Olivier AndréolettiUMR INRA ENVT 1225 -Hôtes-Agents Pathogènes, Ecole Nationale Vétérinaire de Toulouse, Toulouse, 31076, France.
Raymond BujdosoDepartment of Veterinary Medicine, University of Cambridge, Cambridge, CB3 OES, UK.ORCID https://orcid.org/0000-0002-5068-3247
University of Cambridge · GBÉcole Nationale Vétérinaire de Toulouse · FR

Funding

National Centre for the Replacement, Refinement and Reduction of Animals in Research NC/K000462/1National Centre for the Replacement, Refinement and Reduction of Animals in Research NC/R00093X/1
6 · The paper itself

Abstract

Prion diseases are fatal neurodegenerative conditions of humans and vertebrate species. The transmissible prion agent is a novel infectious particle composed principally of PrP

Indexed as

bioassayDrosophilainfectivityinvertebratePrion

Identifiers

PMID29946445
PMCPMC5998032
OpenAlexW2803764468

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.